Regen Med Participation In An RMCE

Published by Nicolas Tierney

June 27, 2019

Abstract

Whether Regen Med co-invests as a shareholder, or separately allocates its own capital against a revenue share arrangement, it succeeds only to the extent that the RMCE, and therefore the Affiliate, succeeds. The objective of both parties is the creation of long-term equity value in the RMCE.

DOWNLOAD WHITE PAPER

Read the latest

March 28, 2023

Clinical Relevance and Statistical Significance. How can we achieve both using Real World Data?

Statistical Significance and Clinical Relevance are two important concepts in the field of medicine, and particularly in clinical research. Being a bit more specific, statistical significance refers to the likelihood that a result is not due to chance.

March 17, 2023

Client Use Case: Generating Value Through Circles From Real-World Evidence

Real-world evidence (RWE) is valuable not only for regulatory compliance, clinical decision-making and tracking adverse events. It can also drive patient engagement, profitability and professional advancement.

January 27, 2023

RegenMed January 2023 Newsletter – Client Activities

In this newsletter, we summarize the work of leading physicians as they develop clinical decision support for common musculoskeletal pathologies. Through the quality improvement and pragmatic studies embedded in their Circles, those clinicians are generating sustained financial and professional value for themselves, and improving patient care, with minimum burden. Moreover, their Circles are often supported by industry.